From: A review of outcome following valve surgery for rheumatic heart disease in Australia
 | All | RHD-related | Non-RHD | P value |
---|---|---|---|---|
N = 17227 | N = 1384 | N = 15843 | ||
Initial admission | ||||
 Ventilation (hours) (median (IQR)) | 11.0(6.8 – 19.0) | 12.0(7.0 – 19.0) | 11.0(6.7 – 19.0) | 0.009 |
 Intensive care unit (ICU) stay (hours) (median (IQR)) | 43.3(23.0 – 72.3) | 42.0(23.0 – 70.8) | 43.5(23.0 – 72.5) | 0.350 |
 Post procedure length of stay (days) (median (IQR)) | 8.0(7.0 – 13.0) | 8.0(7.0 – 13.0) | 8.0(7.0 – 13.0) | 0.648 |
 Re-operation for valve dysfunction (%, 95 % CI) | 0.2(0.1 – 0.3) | 0.4(0.1 – 0.8) | 0.2(0.1 – 0.3) | 0.152 |
 Re-operation not related to valve dysfunction (%, 95 % CI) | 7.0(6.6 – 7.4) | 7.3(6.0 – 8.8) | 7.0(6.6 – 7.4) | 0.652 |
Mortality | ||||
 All cause (%, 95 % CI) | 4.2(3.8 – 4.5) | 3.1(2.2 – 4.3) | 4.3(3.9 – 4.6) | 0.058 |
 Cardiac cause (%, 95 % CI) | 1.5(1.3 – 1.8) | 1.5(0.9 – 2.4) | 1.5(1.3 – 1.8) | 0.122 |
 Non-cardiac cause (%, 95 % CI) | 2.7(2.4 – 2.9) | 1.6(1.0 – 2.6) | 2.8(2.5 – 3.0) | 0.907 |
 Readmission (%, 95 % CI) | 11.2(10.7 – 11.7) | 13.8(12.0 – 15.7) | 11.0(10.5 – 11.5) | 0.002 |
Other complications | ||||
 Readmission for valve dysfunction (%, 95 % CI) | 0.2(0.1 – 0.4) | 0 | 0.2(0.1 – 0.4) | 0.205 |
 Acute kidney injury (%, 95 % CI) | 6.3(5.9 – 6.7) | 6.3(5.1 – 7.7) | 6.3(5.9 – 6.7) | 0.971 |
 New AF (% without prior AF, 95 % CI) | 34.2(33.4 – 35.1) | 33.3(30.1 – 36.6) | 34.3(33.5 – 35.1) | 0.564 |
 Stroke/ TIA (%, 95 % CI) | 2.4(2.2 – 2.6) | 1.6(1.0 – 2.4) | 2.5(2.2 – 2.7) | 0.044 |
 Deep sternal wound infection (%, 95 % CI) | 0.9(0.8 – 1.1) | 1.2(0.7 – 1.0) | 0.9(0.8 – 1.1) | 0.247 |
 Anticoagulant complication (bleeding or embolization) (%, 95 % CI) | 1.7(1.5 – 1.9) | 2.8(2.0 – 3.7) | 1.6(1.4 – 1.8) | 0.002 |
 Heart failure (%, 95 % CI) | 1.9(1.5 – 2.2) | 2.4(1.4 – 3.9) | 1.8(1.5 – 2.1) | 0.274 |
 Septicaemia (positive blood culture with signs of infection)(%, 95 % CI) | 1.6(1.4 – 1.8) | 0.4(0.8 – 2.1) | 0.6(1.4 – 1.8) | 0.476 |